Background In recent decades, an increasing trend has been observed in the prevalence of adenocarcinoma of the esophagogastric junction (AEG), with a greater metastatic probability and worse survival than most cancers [ 1 , 2 ].
← all excerpts
Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
1
—
—